56 related articles for article (PubMed ID: 21424117)
21. Histone H4 deacetylation down-regulates catalase gene expression in doxorubicin-resistant AML subline.
Lee TB; Moon YS; Choi CH
Cell Biol Toxicol; 2012 Feb; 28(1):11-8. PubMed ID: 21968610
[TBL] [Abstract][Full Text] [Related]
22. 5-Aza-2'-deoxycytidine induces histone hyperacetylation of mouse centromeric heterochromatin by a mechanism independent of DNA demethylation.
Takebayashi S; Nakao M; Fujita N; Sado T; Tanaka M; Taguchi H; Okumura K
Biochem Biophys Res Commun; 2001 Nov; 288(4):921-6. PubMed ID: 11688997
[TBL] [Abstract][Full Text] [Related]
23. 5-Azacytidine regulates matrix metalloproteinase-9 expression, and the migration and invasion of human fibrosarcoma HT1080 cells via PI3-kinase and ERK1/2 pathways.
Yu SM; Kim SJ
Int J Oncol; 2016 Sep; 49(3):1241-7. PubMed ID: 27573026
[TBL] [Abstract][Full Text] [Related]
24. Epigenetic regulation of chemokine/chemokine receptor expression.
Baird AM; O'Byrne KJ; Gray SG
Methods Mol Biol; 2013; 1013():185-201. PubMed ID: 23625500
[TBL] [Abstract][Full Text] [Related]
25. Role of BMPs in the regulation of sclerostin as revealed by an epigenetic modifier of human bone cells.
Delgado-Calle J; Arozamena J; Pérez-López J; Bolado-Carrancio A; Sañudo C; Agudo G; de la Vega R; Alonso MA; Rodríguez-Rey JC; Riancho JA
Mol Cell Endocrinol; 2013 Apr; 369(1-2):27-34. PubMed ID: 23415712
[TBL] [Abstract][Full Text] [Related]
26. 5-aza-2'-deoxycytidine has minor effects on differentiation in human thyroid cancer cell lines, but modulates genes that are involved in adaptation in vitro.
Dom G; Galdo VC; Tarabichi M; Tomás G; Hébrant A; Andry G; De Martelar V; Libert F; Leteurtre E; Dumont JE; Maenhaut C; van Staveren WC
Thyroid; 2013 Mar; 23(3):317-28. PubMed ID: 23167291
[TBL] [Abstract][Full Text] [Related]
27. Histone hyperacetylation and DNA methylation interplay during murine spermatogenesis.
Burlibaşa L; Ionescu AC; Dragusanu DM
Zygote; 2019 Oct; 27(5):305-314. PubMed ID: 31412961
[TBL] [Abstract][Full Text] [Related]
28. Influencing Epigenetic Information with a Hydrolytically Stable Carbocyclic 5-Aza-2'-deoxycytidine.
Wildenhof TM; Schiffers S; Traube FR; Mayer P; Carell T
Angew Chem Int Ed Engl; 2019 Sep; 58(37):12984-12987. PubMed ID: 31206985
[TBL] [Abstract][Full Text] [Related]
29. Epigenetics and gene expression.
Gibney ER; Nolan CM
Heredity (Edinb); 2010 Jul; 105(1):4-13. PubMed ID: 20461105
[TBL] [Abstract][Full Text] [Related]
30. Non-epigenetic induction of HEXIM1 by DNMT1 inhibitors and functional relevance.
Sharma V; Montano MM
Sci Rep; 2020 Dec; 10(1):21015. PubMed ID: 33273553
[TBL] [Abstract][Full Text] [Related]
31. Expression of Placental Members of the Human Growth Hormone Gene Family Is Increased in Response to Sequential Inhibition of DNA Methylation and Histone Deacetylation.
Ganguly E; Bock ME; Cattini PA
Biores Open Access; 2015; 4(1):446-56. PubMed ID: 26634190
[TBL] [Abstract][Full Text] [Related]
32. Probing the compressibility of tumor cell nuclei by combined atomic force-confocal microscopy.
Krause M; Te Riet J; Wolf K
Phys Biol; 2013 Dec; 10(6):065002. PubMed ID: 24304807
[TBL] [Abstract][Full Text] [Related]
33. Genome-wide methylation analysis demonstrates that 5-aza-2-deoxycytidine treatment does not cause random DNA demethylation in fragile X syndrome cells.
Tabolacci E; Mancano G; Lanni S; Palumbo F; Goracci M; Ferrè F; Helmer-Citterich M; Neri G
Epigenetics Chromatin; 2016; 9():12. PubMed ID: 27014370
[TBL] [Abstract][Full Text] [Related]
34. Expression profiling of choline and ethanolamine kinases in MCF7, HCT116 and HepG2 cells, and the transcriptional regulation by epigenetic modification.
Ling CS; Yin KB; Cun ST; Ling FL
Mol Med Rep; 2015 Jan; 11(1):611-8. PubMed ID: 25333818
[TBL] [Abstract][Full Text] [Related]
35. Nanos2 promotes differentiation of male germ cells basing on the negative regulation of Foxd3 and the treatment of 5-Azadc and TSA.
Zhang W; Bi Y; Wang Y; Wang M; Li D; Cheng S; Jin J; Li T; Li B; Zhang Y
J Cell Physiol; 2019 Apr; 234(4):3762-3774. PubMed ID: 30146792
[TBL] [Abstract][Full Text] [Related]
36. Matrix Metalloproteinase-1 (MMP1) Upregulation through Promoter Hypomethylation Enhances Tamoxifen Resistance in Breast Cancer.
Kim HW; Park JE; Baek M; Kim H; Ji HW; Yun SH; Jeong D; Ham J; Park S; Lu X; Kang HS; Kim SJ
Cancers (Basel); 2022 Feb; 14(5):. PubMed ID: 35267540
[TBL] [Abstract][Full Text] [Related]
37. Matrix metalloproteinase‑1 expression is regulated by HIF‑1‑dependent and epigenetic mechanisms and serves a tumor‑suppressive role in gastric cancer progression.
Ito K; Kitajima Y; Kai K; Matsufuji S; Yamada K; Egawa N; Kitagawa H; Okuyama K; Tanaka T; Noshiro H
Int J Oncol; 2021 Dec; 59(6):. PubMed ID: 34738626
[TBL] [Abstract][Full Text] [Related]
38. Regulation and involvement of matrix metalloproteinases in vascular diseases.
Amin M; Pushpakumar S; Muradashvili N; Kundu S; Tyagi SC; Sen U
Front Biosci (Landmark Ed); 2016 Jan; 21(1):89-118. PubMed ID: 26709763
[TBL] [Abstract][Full Text] [Related]
39. Epigenetically induced changes in nuclear textural patterns and gelatinase expression in human fibrosarcoma cells.
Poplineau M; Doliwa C; Schnekenburger M; Antonicelli F; Diederich M; Trussardi-Régnier A; Dufer J
Cell Prolif; 2013 Apr; 46(2):127-36. PubMed ID: 23510467
[TBL] [Abstract][Full Text] [Related]
40. Epigenetic regulation of proMMP-1 expression in the HT1080 human fibrosarcoma cell line.
Poplineau M; Dufer J; Antonicelli F; Trussardi-Regnier A
Int J Oncol; 2011 Jun; 38(6):1713-8. PubMed ID: 21424117
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
